EIF4E (eukaryotic translation initiation factor 4E) is a key regulatory protein that controls protein synthesis by recognizing and binding the 7-methylguanosine cap structure of mRNAs, facilitating ribosome recruitment and translation initiation 1. EIF4E functions as part of the eIF4F complex and competes with translational repressors like eIF4E2 and FMRP for cap binding 23. The protein exhibits oncogenic properties when overexpressed, as increased translation is required for cell cycle progression 1. EIF4E phosphorylation by MAP kinase-interacting kinases (Mnks) regulates its activity and is implicated in cancer progression through modulation of oncogene translation 4. Recent studies demonstrate that EIF4E can be targeted by small molecule inhibitors that disrupt its interaction with eIF4G, providing potential therapeutic opportunities 5. The protein shows distinct subcellular localizations under different stress conditions, with various isoforms (eIF4E1, eIF4E2, eIF4E3) displaying differential recruitment to processing bodies and stress granules 6. In cancer contexts, EIF4E activation promotes tumorigenesis through pathways like the PRSS23-eIF4E-c-Myc axis in gastric cancer 7. Under stress conditions when canonical eIF4E1-dependent translation is inhibited, cells can utilize alternative mechanisms involving eIF3d-dependent cap recognition 8.